OncoSec Medical Inc (ONCSQ)

[Waitforit53]

Hey chick, I’m not sure there’s a whole lot of connection there – – maybe with employees but that’s as far as it goes.

Their treatment is administered systemically and therefore yields a high rate of adverse events. Their phase 1 trial yielded interim results where nearly a 3rd of the 34 participants experienced level III and IV adverse events – – I think that’s pretty high – – I’m also curious about the cost being prohibitive.

I am also very biased regarding the Merck/Keytruda Connection. It’s hard to see Merck, after millions of dollars of drug investment, should the multigene cocktail prove as well as we hope, to then just hand over billions in potential profit derived from Oncosec to the highest bidder. Also, I don’t believe the FDA would allow the free interchange of PD – 1’s as though they are all created equal clinically speaking, and that concerns for safety would mean more safety trials, which is not at all expedient of a process for OncoSec. So I think both companies are stuck with each other and so far I don’t think it’s a bad relationship I’m just waiting for them to get married and live happily ever after…OncoSec just has to beef up their dowry of data!?!